Viewing Study NCT03425656


Ignite Creation Date: 2025-12-24 @ 11:24 PM
Ignite Modification Date: 2026-01-04 @ 8:44 AM
Study NCT ID: NCT03425656
Status: COMPLETED
Last Update Posted: 2024-06-28
First Post: 2017-11-21
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Comparing Efficacy and Safety of AryoGen Pharmed Biosimilar Trastuzumab (AryoTrust) Versus Herceptin® in Breast Cancer
Sponsor: AryoGen Pharmed Co.
Organization: